Quick answer: Atopic eczema involves an altered immune response and a weakened skin barrier; the diagnosis alone does not mean you are immunocompromised. Skin infections can occur more easily, but recurrent, severe or unusual infections deserve a separate assessment.
Part of the Eczema Resource Center.
Eczema alone does not establish an immune deficiency
Atopic dermatitis, the most common form of eczema, involves immune activity that is poorly regulated alongside changes in the skin barrier. Immune dysregulation means that the response is not controlled appropriately. Calling the whole immune system either “strong” or “weak” misses this distinction.13
This article focuses on atopic eczema. Other types of eczema have different contributing factors.
| Term | Meaning | Connection to eczema |
|---|---|---|
| Immune dysregulation | An immune response is excessive, misdirected or poorly controlled. | A central feature of atopic eczema. |
| Immunodeficiency | Part of the immune defense is absent or does not work adequately. | Not established by an eczema diagnosis; sometimes a separate condition coexists. |
| Autoimmune disease | The immune system mistakenly targets the body's own tissues. | Atopic eczema is generally classified as an inflammatory, immune-mediated condition rather than a classic autoimmune disease. |
These categories describe different immune problems and can overlap in some disorders. The clinical history matters more than a broad label.34
The skin barrier and immune signals affect each other
The barrier limits moisture loss and outside exposure
The outer skin layer helps hold water in and limits the entry of irritants and microbes. In atopic eczema, changes in barrier proteins and lipids make that protection less effective. Dryness and scratching can damage it further. Genes, environmental exposures and inflammation all contribute; poor hygiene or a parent's failure to moisturize does not explain the disease.1
Type 2 inflammation keeps the cycle active
Type 2 inflammation is a pattern of immune activity involving signaling proteins called cytokines. Two especially important cytokines in atopic eczema are interleukin-4 and interleukin-13, usually shortened to IL-4 and IL-13. Persistent activity in this pathway helps sustain inflammation.
IL-4 and IL-13 can reduce production of filaggrin, a protein important for the skin barrier. This helps explain why barrier damage and inflammation can reinforce each other, and why moisturizing and anti-inflammatory treatment have complementary roles.2
The term “type 2 inflammation” does not identify a particular food trigger. Food reactions need their own history and assessment; see eczema and food avoidance.
Skin infections reflect several local defenses
Cracked, scratched skin gives microbes an easier route through the surface. Inflammation also changes the skin's protective environment. A skin infection therefore does not, by itself, prove a generalized immune deficiency.13
Bacteria on the skin are not always an infection
Eczema-prone skin can carry bacteria without a clinical infection. This is called colonization. Weeping or crusting can also occur during a flare, so these findings alone do not automatically mean antibiotics are needed. A clinician considers symptoms, extent and whether the person is otherwise unwell before choosing treatment.5
New pain, blisters or illness need prompt attention
Increasing pain, warmth, swelling, pus, spreading redness or fever warrant prompt medical advice. A rapidly developing painful rash with clusters of blisters or small punched-out sores may be eczema herpeticum, a herpes simplex infection requiring urgent same-day assessment. Eye involvement needs immediate medical attention.56
The eczema contagiousness and infection guide includes clinical photographs and explains how infection differs from an eczema flare.
Atopic eczema is not usually classified as autoimmune
Immune-mediated means that immune activity contributes to a disease. Autoimmune has a more specific meaning: the immune response targets the body's own tissues. Atopic eczema is generally described as an immune-mediated inflammatory disease, not a classic autoimmune disease.
Researchers continue to study autoimmune features in some people with eczema. This does not mean that an ordinary eczema diagnosis establishes lupus or another autoimmune disorder. New symptoms should be assessed on their own merits.4
Unusual infection patterns deserve a separate evaluation
An allergist/immunologist may be helpful when eczema occurs alongside a concerning infection history. Examples include:
- Repeated deep skin abscesses or recurrent pneumonia.
- Unusual infections or infections that are difficult to clear.
- Repeated need for intravenous antibiotics.
- Poor growth or unexplained weight loss.
- A family history of an immune deficiency.
A clinician weighs the whole pattern, including age, exposures, treatment response and medications, before deciding whether immune testing is appropriate.3
Rare inherited disorders can resemble eczema
Rare inherited immune disorders can include an eczema-like rash. For example, hyper IgE syndromes, named for high levels of the antibody immunoglobulin E (IgE), may cause eczema together with recurrent skin abscesses and lung infections. High IgE alone is not diagnostic, because it can also occur in ordinary atopic eczema. These uncommon conditions should not be assumed from a rash alone.7
Eczema medicines affect immunity in different ways
Some medicines suppress immune defenses
The immune effects of a treatment depend on the medicine. Some medicines that act throughout the body, called systemic medicines, can suppress immune defenses, so the prescriber may recommend monitoring and infection precautions.3
Targeted treatments block specific signals
Other treatments target particular inflammatory signals. Dupilumab, for example, blocks signaling through IL-4 and IL-13. In a pooled analysis of adult eczema trials, overall infection rates were similar to placebo, while serious or severe infections and bacterial and other non-herpetic skin infections were less frequent. This finding does not mean every eczema medicine has the same risks.8
Ask your prescriber about the risks of your specific medicine. Treatment choices and monitoring belong in an individualized plan; the atopic dermatitis care guide covers the broader approach.
Daily care supports the barrier alongside treatment
Gentle cleansing, regular moisturizing and prescribed treatment help manage eczema. Moisturizer supports the skin surface; it does not replace treatment for active inflammation or infection. Persistent symptoms can occur despite careful daily care.9
Daily Wash and Cream support cleansing and moisture
Happy Cappy Daily Shampoo & Body Wash gently cleanses dry, sensitive, eczema-prone skin without added fragrance. Happy Cappy Moisturizing Cream helps reduce moisture loss with petrolatum, while licorice root extract helps calm the look of redness. These products support the skin barrier; they do not boost immunity or treat an infection.
For a simple wash-and-moisturize routine, choose Daily Wash with either the cream tube or jar. Explore the Daily Wash and Moisturizing Cream routine, or follow the fuller daily eczema-care guidance.
References
- NIAMS: Atopic dermatitis, causes and complications
- Howell and colleagues: IL-4, IL-13 and filaggrin expression (2007)
- AAAAI: Primary immunodeficiency, warning signs and evaluation
- National Eczema Association: Atopic dermatitis and autoimmunity (Summer 2023)
- NICE NG190: Secondary bacterial infection of eczema
- American Academy of Dermatology: Cold sores and eczema herpeticum
- Immune Deficiency Foundation: Hyper IgE syndromes
- Eichenfield and colleagues: Infections in dupilumab clinical trials (2019)
- NIAMS: Atopic dermatitis diagnosis, treatment and daily care